NEWSLETTER

Clinically Speaking Newsletter:
November Issue

Issue 7: November 2024
Clinically Speaking, The Difference in PBMs is Clear

Transition of Care Program

  • Provides a grace period for members using a medication subject to clinical review. Pharmacists analyze incumbent data, and, where appropriate, conduct direct, live consultations with prescribers to ensure the best possible results.

Focus on Your Health

  • EmpiRx Health focuses on healthcare outcomes, prioritizing your needs and interests. With an estimated $863 BILLION in pharmacy spend by 2028 in the US, you need a PBM that puts you and your members first.

Population Health Engine

  • EmpiRx Health’s proprietary population health engine helps to optimize patient health and well-being while substantially reducing drug costs.
In Case You Missed It:

EmpiRx Health Exhibited at IFEBP 2024

Thank you to all who stopped by our booth in San Diego at IFEBP 2024. We had a great time testing your knowledge with exciting games of Jeopardy and discussing EmpiRx Health’s clinically-driven PBM model. See you next year in Hawaii!

Thanksgiving at EmpiRx Health

Recently, the EmpiRx Health team took a well-deserved moment to come together—both in the office and virtually—to celebrate one another and reflect on the incredible people who make everything we do possible—our talented team, clients, and partners.

We’re especially thankful for the strong collaboration with our great clients. Our mission is to help keep their members healthy and happy, while substantially reducing costs.

New Blog by EmpiRx Health CEO Danny Sanchez

In a new blog post, EmpiRx Health CEO Danny Sanchez comments on how the recent elections could impact US healthcare policy, especially as it concerns lowering prescription drug costs. As part of the blog, Danny provides four initial recommendations for positive, proactive steps the incoming Administration and Congress can take to limit skyrocketing drug costs:

  • Limit Big Pharma’s Role in Driving Up Drug Costs
  • Increase Transparency in Healthcare, Especially in Drug Pricing
  • Put Pharmacists Back in Pharmacy Benefits Management
  • Enact True PBM Reform Now

To read the full blog, click here.

Read Now!
Featured Case Study

Patient: 46-year-old female

Diagnosis: Narcolepsy

Population Health Management Engine Identified: High-risk patient with comorbidities

  • Clinical Pharmacist discussed patient with prescriber, learning that her condition was absent of Cataplexy; Xyrem is for narcolepsy with cataplexy.
  • Patient’s other conditions could be exacerbated by Xyrem.
  • Clinical pharmacist recommended a clinically appropriate alternative medication for the patient’s narcolepsy.
  • Prescriber agreed to switch the patient to Modafinil tablets, which has resulted in optimal outcomes.

Annual Plan Savings: $108,000

For a Demo of Clinically and to learn more

Call or email us at: 877.361.4338 | info@empirxhealth.com
Contact Us